Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function
出版年份 2016 全文链接
标题
Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function
作者
关键词
-
出版物
NEURO-ONCOLOGY
Volume 18, Issue 9, Pages 1253-1264
出版商
Oxford University Press (OUP)
发表日期
2016-03-23
DOI
10.1093/neuonc/now034
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes
- (2015) Baisakhi Raychaudhuri et al. JOURNAL OF NEURO-ONCOLOGY
- Increase in Both CD14-Positive and CD15-Positive Myeloid-Derived Suppressor Cell Subpopulations in the Blood of Patients With Glioma But Predominance of CD15-Positive Myeloid-Derived Suppressor Cells in Glioma Tissue
- (2015) Paul R. Gielen et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Enterovirus-Infected β-Cells Induce Distinct Response Patterns in BDCA1+ and BDCA3+ Human Dendritic Cells
- (2015) Barbara M. Schulte et al. PLoS One
- HDAC inhibitors and immunotherapy; a double edged sword?
- (2015) Michiel Kroesen et al. Oncotarget
- Dendritic Cell-Based Vaccine for the Treatment of Malignant Glioma: A Systematic Review
- (2014) Xuan Wang et al. CANCER INVESTIGATION
- Dexamethasone potentiates myeloid-derived suppressor cell function in prolonging allograft survival through nitric oxide
- (2014) Jiongbo Liao et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies
- (2014) Kim De Veirman et al. Frontiers in Oncology
- GM-CSF Promotes the Immunosuppressive Activity of Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-
- (2013) G. Kohanbash et al. CANCER RESEARCH
- Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A-Specific T Cells
- (2013) B. Weide et al. CLINICAL CANCER RESEARCH
- Overexpression of S100A9 in human glioma and in-vitro inhibition by aspirin
- (2013) Ning Huang et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
- (2013) David Vasquez-Dunddel et al. JOURNAL OF CLINICAL INVESTIGATION
- Myeloid-Derived Suppressor Cells Regulate Growth of Multiple Myeloma by Inhibiting T Cells in Bone Marrow
- (2013) I. R. Ramachandran et al. JOURNAL OF IMMUNOLOGY
- Circulating and Tumor-Infiltrating Myeloid-Derived Suppressor Cells in Patients with Colorectal Carcinoma
- (2013) Bin Zhang et al. PLoS One
- S100A8/A9 (Calprotectin) Negatively Regulates G2/M Cell Cycle Progression and Growth of Squamous Cell Carcinoma
- (2013) Ali Khammanivong et al. PLoS One
- CD14+S100A9+Monocytic Myeloid-derived Suppressor Cells and Their Clinical Relevance in Non–Small Cell Lung Cancer
- (2012) Po-Hao Feng et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells
- (2012) Dennis Lindau et al. IMMUNOLOGY
- Pro-Inflammatory S100A8 and S100A9 Proteins: Self-Assembly into Multifunctional Native and Amyloid Complexes
- (2012) Thomas Vogl et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Increased Myeloid-Derived Suppressor Cells in Gastric Cancer Correlate with Cancer Stage and Plasma S100A8/A9 Proinflammatory Proteins
- (2012) L. Wang et al. JOURNAL OF IMMUNOLOGY
- Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
- (2011) Rachel F. Gabitass et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment
- (2011) Christopher Jackson et al. Clinical & Developmental Immunology
- Immunotherapy for glioma
- (2011) Gaetano Finocchiaro et al. CURRENT OPINION IN NEUROLOGY
- Vaccines for glioblastoma and high-grade glioma
- (2011) Christopher J Wheeler et al. Expert Review of Vaccines
- Glioblastoma survival in the United States before and during the temozolomide era
- (2011) Derek R. Johnson et al. JOURNAL OF NEURO-ONCOLOGY
- Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma
- (2011) B. Raychaudhuri et al. NEURO-ONCOLOGY
- Corticosteroids in brain cancer patients: benefits and pitfalls
- (2011) Jörg Dietrich et al. Expert Review of Clinical Pharmacology
- The Nature and Timing of Specific Copy Number Changes in the Course of Molecular Progression in Diffuse Gliomas: Further Elucidation of Their Genetic “Life Story”
- (2010) Judith W.M. Jeuken et al. BRAIN PATHOLOGY
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Prognostic significance and mechanism of Treg infiltration in human brain tumors
- (2010) Joannes F.M. Jacobs et al. JOURNAL OF NEUROIMMUNOLOGY
- Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
- (2009) Oliver M. Grauer et al. BRAIN PATHOLOGY
- S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis
- (2009) Julia Németh et al. HEPATOLOGY
- The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer
- (2009) Jan M. Ehrchen et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis
- (2008) Olga Turovskaya et al. CARCINOGENESIS
- Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
- (2008) Pingyan Cheng et al. JOURNAL OF EXPERIMENTAL MEDICINE
- S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway
- (2008) S. Ghavami et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells
- (2008) Georg Varga et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors
- (2008) Joannes F.M. Jacobs et al. NEURO-ONCOLOGY
- S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2
- (2007) Saeid Ghavami et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More